Welcome to
Sysmex Flow Cytometry Austria!

For ordering please make sure you are in your local shop.
If you are from Austria then please continue.
Otherwise please go to your country.

Go to my country Continue

Article successfully added.

CyFlow™ CD70 Purified

CyFlow™ CD70 Purified
Antigen: CD70
Alternative Name: CD27L, Ki-24, TNFSF7
Clone: Ki-24
Application: Flow cytometry
Format/Fluorochrome: Purified
Target Species: Human
Field of Interest: Immunophenotyping
Species of Origin: Mouse
Regulatory Status: RUO
Clonality: monoclonal
Isotype: IgG3
Order number: BR463667

For Research Use Only
Not for use in diagnostic or therapeutic procedures.

Concentration Unit mg/mL Concentration 1 Quantity 0.1 mg Volume 0.1 Immunogen... more
CyFlow™ CD70 Purified
Concentration Unitmg/mL
Concentration1
Quantity0.1 mg
Volume0.1
Immunogen< no data >
Background InformationCD70 (TNFSF7, CD27L) is a 50 kDa type II transmembrane glycoprotein of the TNF superfamily. It is expressed mainly on activated lymphocytes, including NK cells, and forms trimeric structure. CD70 plays a role in T-cell activation, proliferation and differentiation, in enhancing the generation of cytolytic T cells, and in long-term maintenance of T cell memory. It is also involved in B cell differentiation induced by activated plasmacytoid dendritic cells, which also express CD70.
Storage BufferThe reagent is provided in phosphate buffered saline (PBS) solution, pH ≈7.4, containing 0.09% (w/v) sodium azide.
StorageAvoid prolonged exposure to light. Store in the dark at 2-8°C. Do not freeze.
StabilityDo not use after expiration date stamped on vial label.

Specific References

| Israel BF, Pickles RJ, Segal DM, Gerard RD, Kenney SC: Enhancement of adenovirus vector entry into CD70‑positive B‑cell Lines by using a bispecific CD70‑adenovirus fiber antibody. J·Virol. 2001·Jun; 75(11):5215‑21. <·PMID:·11333903·> | Kaufmann Y, Amariglio N, Rosenthal E, Hirsch YJ, Many A, Rechavi G: Proliferation response of leukemic cells to CD70 ligation oscillates with recurrent remission and relapse in a low‑grade lymphoma. J·Immunol. 2005·Nov·15; 175(10):6940‑7. <·PMID:·16272354·> | Kaufmann Y, Amariglio N, Rosenthal E, Hirsch YJ, Many A, Rechavi G: Proliferation response of leukemic cells to CD70 ligation oscillates with recurrent remission and relapse in a low‑grade lymphoma. J·Immunol. 2005·Nov·15; 175(10):6940‑7. <·PMID:·16272354·> | Hashimoto-Okada M, Kitawaki T, Kadowaki N, Iwata S, Morimoto C, Hori T, Uchiyama T: The CD70‑CD27 interaction during the stimulation with dendritic cells promotes naive CD4(+) T cells to develop into T cells producing a broad array of immunostimulatory cytokines in humans. Int·Immunol. 2009·Aug; 21(8):891‑904. <·PMID:·19556308·> | Trebing J, El-Mesery M, Schäfer V, Weisenberger D, Siegmund D, Silence K, Wajant H: CD70‑restricted specific activation of TRAILR1 or TRAILR2 using scFv‑targeted TRAIL mutants. Cell·Death·Dis. 2014·Jan·30; 5:e1035. <·PMID:·24481449·>